The aim of this retrospective study was to determine the impact of adding upfront cranial radiotherapy to EGFR‐TKI in patients with EGFR‐mutant NSCLC with newly diagnosed brain metastases on time to treatment failure, intracranial progression‐free survival, and overall survival. This evidence concerns the gene EGFR and non-small cell lung carcinoma.